Olson Lab Publications

2011

• Stroud, MR, Hansen, SJ, Olson, JM.  In Vivo Bio-imaging Using Chlorotoxin-based Conjugates. Curr Pharm Dec. 2011 Dec;17(38):4362-71. PMID: 22204434
   
• Leary SE, Olson, JM. The molecular classification of medulloblastoma: driving the next generation clinical trials. Curr Opin Pediatr. 2011 Dec 20. [Epub ahead of print]. PMID: 22189395
   
• Paugh BS, Broniscer A, Qu C, Miller CP, Zhang J, Tatevossian RG, Olson JM, Geyer JR, Chi SN, da Silva NS, Onar-Thomas A, Baker JN, Gajjar A, Ellison DW, Baker SJ. Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma. J Clin Oncol. 2011 Oct 20;29(30):3999-4006. Epub 2011 Sep 19.PMID: 21931021
   
• Fouladi M, Stewart CF, Olson J, Wagner LM, Onar-Thomas A, Kocak M, Packer RJ, Goldman S, Gururangan S, Gajjar A, Demuth T, Kun LE, Boyett JM, Gilbertson RJ. Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study. J Clin Oncol. 2011 Sep 10;29(26):3529-34. Epub 2011 Aug 8. PMID: 21825264
   
• Lee S.J., Krauthauser C., Maduskuie V., Fawcett P.T., Olson J.M., Rajasekaran S.A.  Curcumin-induced HDAC inhibition and attenuation of medulloblastoma growth in vitro and in vivo.  BMC Cancer. 2011 Apr 18;11:144. PMID: 21501498
   
• Cho YJ, Tsherniak A, Tamayo P, Santagata S, Ligon A, Greulich H, Berhoukim R, Amani V, Goumnerova L, Eberhart CG, Lau CC, Olson JM, Gilbertson RJ, Gajjar A, Delattre O, Kool M, Ligon K, Meyerson M, Mesirov JP, Pomeroy SL. Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. J Clin Oncol. 2011 Apr 10;29(11):1424-30. Epub 2010 Nov 22. PMID: 21098324
   
• Wu C, Hansen SJ, Hou Q, Yu J, Zeigler M, Jin Y, Burnham DR, McNeill JD, Olson JM, Chiu DT. Design of highly emissive polymer dot bioconjugates for in vivo tumor targeting. Angew Chem Int Ed Engl. 2011 Apr 4;50(15):3430-4. doi: 10.1002/anie.201007461. Epub 2011 Mar 4. PMID: 21381164
   
• Cherry T.J., Wang S., Bormuth I., Schwab M., Olson J., Cepko C.L. NeuroD factors regulate cell fate and neurite stratification in the developing retina. J Neurosci. 2011 May 18;31(20):7365-79. PMID: 21593321
   
• Akcan M., Stroud M.R., Hansen S.J., Clark R.J., Daly N.L., Craik D.J., Olson J.M.  Chemical re-engineering of chlorotoxin improves bioconjugation properties for tumor imaging and targeted therapy. J Med Chem. 2011 Jan 6. [Epub ahead of print].

2010

• Giussani C, Poliakov A, Ferri RT, Plawner LL, Browd SR, Shaw DW, Filardi TZ, Hoeppner C, Geyer JR, Olson JM, Douglas JG, Villavicencio EH, Ellenbogen RG, Ojemann JG. DTI fiber tracking to differentiate demyelinating diseases from diffuse brain stem glioma. Neuroimage. 2010 Aug 1;52(1):217-23. Epub 2010 Apr 2. PMID: 20363335
   
• Lee M. J.-E., Veiseh O., Bhattarai N., Sun C., Hansen S.J., Ditzler S., Knoblaugh S., Lee D., Ellenbogen R., Zhang M., Olson J.M.  Rapid pharmacokinetic and biodistribution studies using chlorotoxin-conjugated iron oxide nanoparticles: A novel non-radioactive method. PLoS ONE 5(3): e9536, 2010. PMCID: PMC2832013.
   
• Benn C.L., Luthi-Carter R., Kuhn A., Sadri-Vakili G., Blankson K.L., Dalai S.C., Goldstein D.L., Spires T.L., Pritchard
  J., Olson, J.M., van Dellen A., Hannan A.H., Cha J.-H.  Environmental enrichment reduces neuronal intranuclear inclusion load but has no effect on messenger RNA expression in a mouse model of Huntington disease. Journal of Neuropathology and Experimental Neurology 69(8):817-827, 2010.
   
• Ravanpay A.C., Hansen S.J., Olson J.M.  Transcriptional inhibition of REST by NeuroD2 during neuronal differentiation.  Molecular and Cellular Neuroscience 44(2):178-189, 2010. PMCID: PMC2866295 [Available on 2011/6/1].
   
• Hatton B.A., Villavicencio E.H., Pritchard J., LeBlanc M., Hansen S., Ulrich M., Ditzler S., Pullar B., Stroud M.R., Olson J.M.  Notch signaling is not essential in sonic hedgehog-activated medulloblastoma. Oncogene 29(26):3865-3872, 2010. PMCID: PMC2896441.
   
• Lee M.J., Veiseh O., Bhattarai N., Sun C., Hansen S.J., Ditzler S., Knoblaugh S., Lee D., Ellenbogen R., Zhang M., Olson J.M.  Rapid pharmacokinetic and biodistribution studies using chlorotoxin-conjugated iron oxide nanoparticles: a novel non-radioactive method. PLoS ONE 5(3): e9536, 2010. PMCID: PMC2832013.

2009

• Veiseh, O., Sun, C., Fang, C.,  Bhattarai, N.,  Gunn, J.,  Kievit, F., Du, K., Pullar, B., Lee, D.,  Ellenbogen, R.G., Olson, J., Zhang, M.  Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier.  Cancer Res 69:(15), 2009. PMCID: PMC2742601.
   
• Diede, S.J., Guenthoer, J., Geng, L.N., Mahoney, S.E., Marotta, M., Olson, J.M., Tanaka, H., Tapscott, S.J.  DNA methylation of developmental genes in pediatric medulloblastomas identified by denaturation analysis of methylation differences. Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):234-9. Epub 2009 Dec 4. PMID: 19966297
   
• Kievit F.M., Veiseh O., Bhattarai N., Fang C., Gunn J.W., Lee D., Ellenbogen R.G., Olson J.M., Zhang M.  PEI-PEG-Chitosan Copolymer Coated Iron Oxid Nanoparticles for Safe Gene Delivery: synthesis, complexation, and transfection.  Adv Funct Mater 19(14):2244-2251, 2009. PMCID: PMC2756666. 

2008

• Sun, C., Fang, C., Stephen, Z., Veiseh, O., Hansen, S., Lee, D., Ellenbogen, R.G., Olson, J., Zhang, M.  Tumor-targeted drug delivery and MRI contrast enhancement by chlorotoxin-conjugated iron oxide nanoparticles.  Nanomedicine 3(4):495-505, 2008.  PMCID: PMC2890026.
   
• Ravanpay, A., Olson, J.M.  E protein dosage influences brain development more than family member identity.  Journal of Neuroscience Research 86(7):1472-1481, 2008.
   
• Spiller, S.E., Ditzler, S.H. Pullar, B.J., Olson, J.M.  Response of preclinical medulloblastoma models to combination therapy with 13-cis retinoic acid and suberoylanilide hydroxamic acid (SAHA).  Journal of Neuro-Oncology 87(2):133-141, 2008.
   
• Hatton, B.A., Villavicencio, E.H., Tsuchiya, K.D., Pritchard, J.I., Ditzler, S., Pullar, B., Hansen, S., Knoblaugh, S.E., Lee, D., Eberhart, C.G., Hallahan, A.R., Olson, J.M.  The Smo/Smo model: Hedgehog-induced medulloblastoma with 90% incidence and leptomeningeal spread.  Cancer Research 68(6): 1768-76, 2008. 
   
• Sun, C., Veiseh, O., Gunn, J., Fang, C., Hansen, S., Lee, D., Sze, R., Ellenbogen, J., Olson, J., Zhang, M.  In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes.  Small 4(3):372-379, 2008. PMCID: PMC2692358.
   
• Pritchard, J.I., Olson, J.M.  Methylation of PTCH1, the Patched-1 gene, in a panel of primary medulloblastomas.  Cancer Genetics and Cytogenetics 180(1):47-50, 2008. PMCID: PMC2219922.

2007

• Strand, A.D., Aragaki, A.K., Baquet, Z.C., Hodges, A., Cunningham, P., Holmans, P., Jones, K.R., Jones, L., Kooperberg, C., Olson, J.M. Conservation of regional gene expression in mouse and human brain. PLoS Genet. 3(4):e59, 2007. Full Text
   
• Kaltenbach, L.S., Romero, E., Becklin, R.R., Chettier, R., Bell, R., Phansalkar, A., Strand, A., Torcassi, C., Savage, J., Hurlburt, A., Cha, G.H., Ukani, L., Chepanoske, C.L., Zhen, Y., Sahasrabudhe, S., Olson, J., Kurschner, C., Ellerby, L.M., Peltier, J.M., Botas, J., Hughes, R.E. Huntingtin interacting proteins are genetic modifiers of neurodegeneration. PLoS Genet. 3(5):e82, 2007. Full Text
   
• Veiseh, M., Gabikian, P., Bahrami, S.-B., Veiseh, O., Zhang, M., Hackman, R.C., Ravanpay, A.C., Stroud, M.R., Kusuma, Y., Hansen, S.J., Kwok, D., Muñoz, N.M., Sze, R.W., Grady, W.M., Greenberg, N.M., Ellenbogen, R.G., Olson, J.M. Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intra-operative visualization of cancer foci. Cancer Research 67(14):6882-88, 2007. PMID: 17638899. Full Text
   
• Kuhn, A., Goldstein, D.R., Hodges, A., Strand, A.D., Sengstag, T., Kooperberg, C., Becanovic, K., Pouladi, M.A., Sathasivam, K., Cha, J.-H. J., Hannan, A.J., Hayden, M.R., Leavitt, B.R., Dunnett, S.B., Ferrante, R.J., Albin, R., Shelbourne, P., Delorenzi, M., Augood, S.J., Faull, R.L.M., Olson, J.M., Bates, G.P., Jones, L., Luthi-Carter, R. Mutant huntingtin’s effects on striatal gene expression in mice recapitulate changes observed in human Huntington’s disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage. Human Molecular Genetics 16(15):1845-61, 2007. Full Text
   
• Strand A.D., Baquet Z.C., Aragaki, A.K., Holmans, P., Yang, L., Cleren, C., Beal, M.F., Jones, L., Kooperberg, C., Olson, J.M., Jones, K.R. Microarray profiling of animal models supports a link between BDNF loss and Huntington's disease.Journal of Neuroscience, 27(43): 11758-68, 2007
   
• Strand, A.D., Baquet, Z.C., Aragaki, A.K., Holmans, P., Yang, L., Cleren, C., Beal, M.F., Jones, L., Kopperberg, C., Olson, J.M., Jones, K.R. Expression Profiling of Huntington's disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration. J Neuosci, 27(43):11758-68, 2007. Full Text

2006

• Douglas, J.G., Rockhill, J.K., Olson, J.M., Ellenbogen, R.G., Geyer, J.R. Cisplatin-based chemotherapy followed by focal, reduced-dose irradiation for pediatric primary central nervous system germinomas. Journal of Pediatric Hematology 28(1):36-39, 2006. Full Text
   
• L., Illes, K., Pallos, J., Bodai, L., Wu, J., Strand, A., Schweitzer, E.S., Olson, J.M., Kazantsev, A., Marsh, J.L., Thompson, L.M. Mutant huntingtin alters MAPK signaling pathways in PC12 and striatal cells: ERK1/2 protects against mutant huntingtin-associated toxicity. Human Molecular Genetics 15(2):273-285, 2006. Full Text
   
• Hodges, A., Strand, A.D., Aragaki, A.K., Kuhn, A., Sengstag, T., Hughes, G., Elliston, L.A., Hartog, C., Goldstein, D.R., Thu, D., Hollingsworth, Z.R., Collin, F., Synek, B., Holmans, P.A., Young, A.B., Wexler, N.S., Delorenzi, M., Kooperberg, C., Augood, S.J., Faull, R.L, Olson, J.M., Jones, L., Luthi-Carter, R. Regional and cellular gene expression changes in human Huntington's disease brain. Human Molecular Genetics 15(6):965-977, 2006. Full Text
   
• Ince-Dunn, G., Hall, B.J., Hu, S.C., Ripley, B., Huganir, R.L., Olson, J.M., Tapscott, S.J.,Ghosh, A.Regulation of thalamocortical patterning and synaptic maturation by neuroD2. Neuron 49(5):683-695, 2006. Full Text
   
• Spiller, S.E., Ravanpay, A.C., Hahn, A.W., Olson, J.M.Suberoylanilide hydroxamic acid is effective in preclinical studies of medulloblastoma. Journal of Neuro-Oncology 79(3):259-70, 2006. PMID: 16645722. Full Text
   
• Lin, C.-H., Tapscott, S.J., Olson, J.M. Congenital hypothyroidism (cretinism) in neuroD2-deficient mice. Molecular and Cellular Biology 26(11):4311-5, 2006 PMID: 16705180. Full Text
   
• Jones, L., Goldstein, D.R., Hughes, G., Strand, A.D., Collin, F., Dunnett, S.B., Kooperberg, C., Aragaki, A., Olson, J.M., Augood, S.J., Faull, R.L.M., Luthi-Carter, R., Moskvina, V., Hodges, A.K. Assessment of the relationship between pre-chip and post-chip quality measures for Affymetrix GeneChip expression data. BMC Bioinformatics 19(7):211, 2006. Full Text
   
• Fan, W., Khalid, N., Hallahan, A.R., Olson, J.M., Zhao, L.P. A statistical method for predicting splice variants between two groups of samples using GeneChip expression array data. Theor Biol Med Model 3:19, 2006. PMID: 16603076. Full Text
   
• Strand, A.D., Aragaki, A.K., Baquet, Z.C., Hodges, A., Cunningham, P., Holmans, P., Jones, K.R., Jones, L., Kooperberg, C., Olson, J.M. Regional and cellular gene expression changes in human Huntington's disease brain. Human Molecular Genetics 15(6):965-77, 2006. Full Text
   
• Hatton, B.A., Pritchard, J.I., Olson, J.M. Nervous system cancer models: medulloblastoma. Drug Discovery Today: Disease Models 3(2): 167-74, 2006.
   
• Hatton, B.A., Knoepfler. P.S., Kenney, A.M., Rowitch, D.H., de Alborán, I.M., Olson, J.M., Eisenman, R.N. N-myc is an essential downstream effector of Shh signaling during both normal and neoplastic cerebellar growth. Cancer Research 66(17):8655-61, 2006. PMID: 16951180. Full Text

2005

• Lin, C.-H., Hansen, S., Wang, Z., Storm, D.R., Tapscott, S.J., Olson, J.M. The dosage of the neuroD2 transcription factor regulates amygdala development and emotional learning. Proceedings of the National Academy of Sciences 102(41): 14877-14882, 2005. PMID: 16203979. Full Text
    
• Veiseh, O., Sun, C., Gunn, J., Kohler, N., Gabikian, P., Lee, D., Bhattarai, N., Ellenbogen, R., Sze, R., Hallahan, A., Olson, J., Zhang, M. An optical and MRI multifunctional nanoprobe for targeting gliomas. Nano Letters 5(6): 1003-1008, 2005. PMID: 15943433. 
   
• Strand, A.D., Aragaki, A.K., Shaw, D., Bird, T., Holton, J., Turner, C., Tapscott, S.J., Tabrizi, S.J., Schapira, A.H., Kooperberg, C., Olson, J.M. Gene expression in Huntington’s disease skeletal muscle: a potential biomarker. Human Molecular Genetics 14(13):1863-1876, 2005. Full Text | Abstract
   
• Kooperberg, C., Aragaki, A., Strand, A.D., Olson, J.M. Significance testing for small microarray experiments. Statistics in Medicine 24:2281-2298, 2005. Full Text
   
• Fan, W., Pritchard, J.I., Olson, J.M., Khalid, N., and Zhao, L.P. A class of models for analyzing GeneChip® gene expression analysis array data. BMC Genomics 6:16, 2005. PMID: 15710039. Full Text | Abstract
   
• Valenza, M., Rigamonti, D., Goffredo, D., Zuccato, C., Fenu, S., Jamot, L., Strand, A., Tarditi, A., Woodman, B., Racchi, M., Mariotti, C., DiDonato, S., Corsini, A., Bates, G., Pruss, R., Olson, J.M., Sipione, S., Tartari, M., Cattaneo, E. Dysfunction of the cholesterol biosynthetic pathway in Huntington's Disease. Journal of Neuroscience 25(43):9932-9939, 2005. Full Text
   
• Benn, C.L., Landles, C., Li, H., Strand, A.D., Woodman, B., Sathasivam, K., Li, S.H., Ghazi-Noori, S., Hockly, E., Faruque, S.M., Cha, J.H., Sharpe, P.T., Olson, J.M., Li, X.J., Bates, G. Contribution of nuclear and extranuclear polyQ to neurological phenotypes in mouse models of Huntington’s disease. Human Molecular Genetics 14(20): 3065-3078, 2005. Full Text

2004

• Hallahan, A.R., Pritchard, J.I., Hansen, S., Benson, M., Stoeck, J., Hatton, B.A., Russell, T.L., Bernstein, I.D., Beachy, P.A., Olson, J.M. The SmoA1 mouse model reveals that Notch signaling is critical for the growth and survival of Sonic Hedgehog-induced medulloblastomas. Cancer Research 64:7794-7800, 2004. PMID: 15520185. Full Text | Abstract
   
• Olson, J.M. and Hallahan, A.R. P38 MAP Kinase: a convergence point in cancer therapy. Trends in Molecular Medicine 10(3):125-129, 2004. PMID: 15102355. Full Text | Abstract
   
• Lin, C.H., Stoeck, J., Ravanpay, A.C., Guillemot, F., Tapscott, S.J., and Olson, J.M. Regulation of neuroD2 expression in mouse brain. Developmental Biology 265(1):234-245, 2004. PMID: 14697366. Full Text  | Abstract
   

2003

• Hallahan, A.R., Pritchard, J.I., Chandraratna, R.A., Ellenbogen, R., Geyer, J.R., Overland, R.P., Strand, A.D., Tapscott, S.J., and Olson, J.M. BMP- 2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect. Nature Medicine 9(8):1033-1038, 2003. PMID: 12872164. Full Text | Abstract 
   
• Gilbertson, R.J., Hill, D.A., Hernan, R., Kocak, M., Geyer, R., Olson, J., Gajjar, A, Rush, L., Hamilton, R.L., Finkelstein, S.D., and Pollack, I.F. ERBB1 is amplified and overexpressed in high-grade diffusely infiltrative pediatric brain stem glioma. Clinical Cancer Research 9(10 Pt1): 3620-3624, 2003. Full Text
   
• Ditzler, S., Stoeck, J., LeBlanc, M., Kooperberg, C., Hansen, S., Coppin, L., Olson, J.M. A rapid neurobehavioral assessment reveals that FK506 delays symptom onset in R6/2 Huntington’s disease mice. PreClinica 1(3):115-126, 2003.  Abstract

2002

• Berman, D.M., Karhadkar, S.S., Hallahan, A.R., Pritchard, J.I., Eberhart, C.G., Watkins, D.N., Chen, J.K., Cooper, M.K., Taipale, J., Olson, J.M., and Beachy, P.A.Medulloblastoma growth inhibition by hedgehog pathway blockade. Science 297:1559-1561, 2002. PMID: 12202832. Full Text | Abstract

• Kooperberg, C., Sipione, S., LeBlanc, M., Strand, A.D., Cattaneo, E., Olson, J.M. Evaluating test statistics to select interesting genes in microarray experiments. Human Molecular Genetics 11(19):2223-2232, 2002. Full Text
   
• Strand, A.D., Olson, J.M., Kooperberg, C. Estimating the statistical significance of gene expression changes observed with oligonucleotide arrays. Human Molecular Genetics 11(19): 2207-2221, 2002. Full Text | Abstract
   
• Xu, X.L., Olson, J.M., Zhao, L.P. A regression based method to identify differentially expressed genes in microarray time course studies and its application in an inducible Huntington’s disease transgenic model. Human Molecular Genetics 11(17):1977-1985, 2002. Full Text | Abstract
   
• Lieberman, A.P., Harmison, G., Strand, A.D., Olson, J.M., Fischbeck, K.H. Altered androgen receptor function due to polyglutamine expansion. Human Molecular Genetics 11(17):1967-1976, 2002.  Abstract
   
• Sipione, S., Rigamonti, D., Valenza, M., Zuccato, C., Conti, L., Pritchard, J., Kooperberg, C., Olson, J.M., Cattaneo, E. Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses. Human Molecular Genetics 11(17):1953-1965, 2002. Full Text | PDF | Abstract
   
• Chan, E.Y.W., Luthi-Carter, R., Strand, A., Solano, S.M., Hanson, S.A., DeJohn, M.M., Kooperberg, C., Chase, K.O., DiFiglia, M., Young, A.B., Leavitt, B.R., Cha, J.-H.J., Aronin, N., Hayden, M.R., Olson, J.M. Increased huntingtin protein length reduces the severity of polyglutamine-induced gene expression changes in mouse models of Huntington disease. Human Molecular Genetics 11(17):1939-1951, 2002. Full Text | Abstract
   
• Luthi-Carter, R., Strand, A.D., Hanson, S.A., Kooperberg, C., Schilling, G., LaSpada, A.R., Merry, D.E., Young, A.B., Ross, C.A., Borchelt, D.R., Olson, J.M. Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington’s disease mouse models reveal context-independent effects. Human Molecular Genetics 11(17):1927-1937, 2002. Full Text | Abstract
   
• Luthi-Carter R., Hanson S.A., Strand A.D., Bergstrom D.A., Chun W., Peters N.L., Woods A.M., Chan E.Y., Kooperberg C., Krainc D., Young A.B., Tapscott S.J., Olson J.M. Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain. Hum Mol Genet 11(17): 1911-26, 2002. Full Text | Abstract
   
• Pomeroy S.L., Tamayo P., Gaasenbeek M., Sturla L.M., Angelo M., McLaughlin M.E., Kim J.Y., Goumnerova L.C., Black P.M., Lau C., Allen J.C., Zagzag D., Olson J.M., Curran T., Wetmore C., Biegel J.A., Poggio T., Mukherjee S., Rifkin R., Califano A., Stolovitzky G., Louis D.N., Mesirov J.P., Lander E.S., Golub T.R. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415(6870):436-42, 2002. Full Text | Abstract
   
• Strand, A.D., Olson, J.M., Kooperberg, C. Estimating the statistical significance of gene expression changes observed with oligonucleotide arrays.  Hum Mol Genet. 11(19):2207-21, 2002.  Full Text

2001

• Hughes R.E., Lo R.S., Davis C., Strand A.D., Neal C.L., Olson J.M., Fields S. Altered transcription in yeast expressing expanded polyglutamine. Proc. Natl. Acad. Sci. USA. Nov 6;98(23):13201-6, 2001. Full Text | Abstract
   
• Kiehl, T.-K., Olson, J.M., and Pulst, S.-M. The Hereditary Disease Array Group (HDAG) - Microarrays, Models and Mechanisms: A Collaboration Update. Current Genomics 2:221-229, 2001.

• J.G., Olson J.M., Tapscott S.J., Zhao L.P.. An efficient and robust statistical modeling approach to discover differentially expressed genes using genomic expression profiles. Genome Res 11(7): 1227-36, 2001. Full Text | Abstract
   
• Olson J.M., Asakura A., Snider L., Hawkes R., Strand A., Stoeck J., Hallahan A., Pritchard J., Tapscott S.J. NeuroD2 is necessary for development and survival of central nervous system neurons. Dev Biol 234(1): 174-87, 2001. PMID: 11356028. Full Text | Abstract
   
• Hughes R.E., Olson J.M. Therapeutic opportunities in polyglutamine disease. Nature Med 7(4): 419-23, 2001. Full Text | Abstract
   
• Johnston, D.L., Benjamin, D.R., and Olson, J.M. Gastrointestinal Stromal Tumor in a Patient with Previous Neuroblastoma. J. Ped. Hem. Oncol. 23:255-256, 2001.

2000

• Luthi-Carter R., Strand A., Peters N.L., Solano S.M., Hollingsworth Z.R., Menon A.S., Frey A.S., Spektor B.S., Penney E.B., Schilling G., Ross C.A., Borchelt D.R., Tapscott S.J., Young A.B., Cha J.H., Olson J.M.. Decreased expression of striatal signaling genes in a mouse model of Huntington's disease. Hum Mol Genet 9(9): 1259-71, 2000. Full Text | Abstract
   
• Farah M.H., Olson J.M., Sucic H.B., Hume R.I., Tapscott S.J., Turner D.L. Generation of neurons by transient expression of neural bHLH proteins in mammalian cells. Development 127(4): 693-702, 2000. Full Text | Abstract | PDF